Recent updates to guidelines mean that more people living with HIV are likely to be offered moderate intensity statin therapy. The drug-drug interaction potential between antiretrovirals and statins varies depending on the elimination pathway of statins and the inhibition/induction potential of antiretrovirals.
This new Prescribing Resource give details of the interactions between key ARVs and atorvastatin, pravastatin or rosuvastatin, along with recommendations for the management of the interactions.
The Prescribing Resource can be found under the Prescribing and Dosing Guidance heading of the Prescribing Resource section of the website or by clicking here.
